Daniel Vitt | Chief Executive officer, President & Director |
Glenn Whaley | Vice President of Finance and Principal Financial & Accounting Officer |
Thomas Smith | SVB Leerink |
Yasmeen Rahimi | Piper Sandler |
Andreas Argyrides | Wedbush |
Matthew Kaplan | Lautenbach Tallmann |
Boobalan Pachaiyappan | H.C. Wainwright |
Zegbeh Jallah | Roth Capital |
Good morning and welcome to Immunic's First Quarter 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today's call.
Speaking on the call are Dr. Daniel Vitt, our Chief Executive Officer and President as well as Glenn Whaley, our recently promoted Chief Financial Officer.